Showing results (451-460 of 592) with videos related to
Sort By:
Pageof 60
Journal of Experimental & Clinical Cancer Research : CR|July 2, 2024
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patientsElena Giordani, Matteo Allegretti, Alberto Sinibaldi, et al.Journal of Personalized Medicine|March 27, 2026
Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 InhibitorsIlaria Poli, Gaia Rachele Oliva, Ginevra Mongelli, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lungAnna Caliò, Alessia Nottegar, Eliana Gilioli, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2025
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapyFederico Monaca, Igor Gomez-Randulfe, Ana Sofia Parreira, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2015
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell CarcinomaFrancesco Massari, Chiara Ciccarese, Emilio Bria, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2025
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023)Giovanni Maria Iannantuono, Charalampos S Floudas, Marco Filetti, et al.Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.Journal of the National Cancer Institute|May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Fabiola Giudici, Mario Giuliano, et al.Pageof 60